Search Results Search Sort by RelevanceMost Recent Case and Commentary Feb 2017 How Should Therapeutic Decisions about Expensive Drugs Be Made in Imperfect Environments? Leonard M. Fleck, PhD and Marion Danis, MD Clinicians can be patient advocates, resource stewards, and promote good financial choices about care. AMA J Ethics. 2017;19(2):147-156. doi: 10.1001/journalofethics.2017.19.2.ecas2-1702. Case and Commentary Jan 2005 Mr. Douglas's Angiogram Gets a Second Look, Option Assessment Faith Lagay, PhD Virtual Mentor. 2005;7(1):28-34. doi: 10.1001/virtualmentor.2005.7.1.ccas6a-0501. Case and Commentary May 2004 Disaster Triage James F. Childress, PhD Virtual Mentor. 2004;6(5):206-208. doi: 10.1001/virtualmentor.2004.6.5.ccas2-0405. Case and Commentary Mar 2004 HMO-Dictated Patient Discharge, Commentary 1 Lisa Anderson-Shaw, DrPH, MA, MSN Virtual Mentor. 2004;6(3):112-116. doi: 10.1001/virtualmentor.2004.6.3.ccas3-0403. Case and Commentary Mar 2004 HMO-Dictated Patient Discharge, Commentary 2 Linda MacDonald Glenn, JD, LLM Virtual Mentor. 2004;6(3):112-116. doi: 10.1001/virtualmentor.2004.6.3.ccas3-0403. Case and Commentary Aug 2016 Ethical Questions about Platelet Transfusions at the End of Life John P. Sherbeck, MD and Renee D. Boss, MD The allocation of scarce resources, such as HLA platelets, involves a conflict between the medical ethics principles of beneficence and social justice. AMA J Ethics. 2016;18(8):764-770. doi: 10.1001/journalofethics.2016.18.8.ecas1-1608. Case and Commentary Nov 2016 Requests for VIP Treatment in Pathology: Implications for Social Justice and Systems-Based Practice Virginia Sheffield and Lauren B. Smith, MD Preferential treatment of “very important” patients is not only unjust but also can compromise patient safety, which is overlooked in medical ethics. AMA J Ethics. 2016;18(8):786-792. doi: 10.1001/journalofethics.2016.18.8.ecas4-1608. Case and Commentary Nov 2003 Please Don't Say Anything: Partner Notification and the Patient-Physician Relationship, Commentary 1 Ronald Epstein, MD Virtual Mentor. 2003;5(11):485-488. doi: 10.1001/virtualmentor.2003.5.11.ccas2-0311. Case and Commentary Nov 2003 Please Don't Say Anything: Partner Notification and the Patient-Physician Relationship, Commentary 2 James C. Thomas, MPH, PhD Virtual Mentor. 2003;5(11):489-491. doi: 10.1001/virtualmentor.2003.5.11.ccas2-0311. Case and Commentary Nov 2003 Please Don't Say Anything: Partner Notification and the Patient-Physician Relationship, Commentary 3 Gregory W. Rutecki, MD Virtual Mentor. 2003;5(11):492-495. doi: 10.1001/virtualmentor.2003.5.11.ccas2-0311. Pagination First page « First Previous page ‹ Previous Page 1 Page 2 Page 3 Current page 4 Page 5 Page 6 Page 7 Page 8 Page 9 Next page Next › Last page Last »
Case and Commentary Feb 2017 How Should Therapeutic Decisions about Expensive Drugs Be Made in Imperfect Environments? Leonard M. Fleck, PhD and Marion Danis, MD Clinicians can be patient advocates, resource stewards, and promote good financial choices about care. AMA J Ethics. 2017;19(2):147-156. doi: 10.1001/journalofethics.2017.19.2.ecas2-1702.
Case and Commentary Jan 2005 Mr. Douglas's Angiogram Gets a Second Look, Option Assessment Faith Lagay, PhD Virtual Mentor. 2005;7(1):28-34. doi: 10.1001/virtualmentor.2005.7.1.ccas6a-0501.
Case and Commentary May 2004 Disaster Triage James F. Childress, PhD Virtual Mentor. 2004;6(5):206-208. doi: 10.1001/virtualmentor.2004.6.5.ccas2-0405.
Case and Commentary Mar 2004 HMO-Dictated Patient Discharge, Commentary 1 Lisa Anderson-Shaw, DrPH, MA, MSN Virtual Mentor. 2004;6(3):112-116. doi: 10.1001/virtualmentor.2004.6.3.ccas3-0403.
Case and Commentary Mar 2004 HMO-Dictated Patient Discharge, Commentary 2 Linda MacDonald Glenn, JD, LLM Virtual Mentor. 2004;6(3):112-116. doi: 10.1001/virtualmentor.2004.6.3.ccas3-0403.
Case and Commentary Aug 2016 Ethical Questions about Platelet Transfusions at the End of Life John P. Sherbeck, MD and Renee D. Boss, MD The allocation of scarce resources, such as HLA platelets, involves a conflict between the medical ethics principles of beneficence and social justice. AMA J Ethics. 2016;18(8):764-770. doi: 10.1001/journalofethics.2016.18.8.ecas1-1608.
Case and Commentary Nov 2016 Requests for VIP Treatment in Pathology: Implications for Social Justice and Systems-Based Practice Virginia Sheffield and Lauren B. Smith, MD Preferential treatment of “very important” patients is not only unjust but also can compromise patient safety, which is overlooked in medical ethics. AMA J Ethics. 2016;18(8):786-792. doi: 10.1001/journalofethics.2016.18.8.ecas4-1608.
Case and Commentary Nov 2003 Please Don't Say Anything: Partner Notification and the Patient-Physician Relationship, Commentary 1 Ronald Epstein, MD Virtual Mentor. 2003;5(11):485-488. doi: 10.1001/virtualmentor.2003.5.11.ccas2-0311.
Case and Commentary Nov 2003 Please Don't Say Anything: Partner Notification and the Patient-Physician Relationship, Commentary 2 James C. Thomas, MPH, PhD Virtual Mentor. 2003;5(11):489-491. doi: 10.1001/virtualmentor.2003.5.11.ccas2-0311.
Case and Commentary Nov 2003 Please Don't Say Anything: Partner Notification and the Patient-Physician Relationship, Commentary 3 Gregory W. Rutecki, MD Virtual Mentor. 2003;5(11):492-495. doi: 10.1001/virtualmentor.2003.5.11.ccas2-0311.